Pacific Biosciences of California has announced its participation in the iHope initiative, a program led by the Genetic Alliance aimed at extending long-read whole genome sequencing to underserved families globally. This collaboration seeks to advance research in rare diseases by providing access to crucial genomic technologies. The move reinforces Pacific Biosciences of California’s dedication to improving healthcare outcomes for communities worldwide that currently lack adequate genetic testing capabilities.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Pacific Biosciences of California joins iHope to expand genomic sequencing access
Pacific Biosciences of California has announced its participation in the iHope initiative, a program led by the Genetic Alliance aimed at extending long-read whole genome sequencing to underserved families globally. This collaboration seeks to advance research in rare diseases by providing access to crucial genomic technologies. The move reinforces Pacific Biosciences of California’s dedication to improving healthcare outcomes for communities worldwide that currently lack adequate genetic testing capabilities.